Case Studies

Yunfeng Zhu, PharmD Candidate, Diana M. Sobieraj, PharmD, and Craig I. Coleman, PharmD
Published Online: Wednesday, June 19, 2013
Follow Pharmacy_Times:
Case 1
CS, a 77-year-old man recently diagnosed with atrial fibrillation, presents to your pharmacy with a new prescription for dabigatran etexilate 150 mg twice daily. His past medical history is significant for hypertension and type 2 diabetes (and therefore has a CHADS2 score of 3). He is currently taking metoprolol, lisinopril, and metformin. Upon talking with CS you find out that he uses a pillbox to manage his medications.
As CS’s pharmacist, what important counseling point regarding his dabigatran should you offer?
 
Case 2
PH, a 33-year-old woman, presents to your healthcare clinic with a 10-year history of worsening plaque psoriasis currently affecting 15% of her body. The psoriatic plaques are found on both her trunk and extremities. She has tried a variety of topical steroids and a topical vitamin D analog as well as PUVA and NB-UVB phototherapy treatment in the last 3 years, none of which optimally controlled her psoriasis. She has a history of obesity and was recently diagnosed with hypertension for which olmesartan 20 mg daily was prescribed. Her physician asks for your input on which therapy PH should try next for her psoriasis.
How do you, the pharmacist, respond to PH’s physician?


Related Articles
Two new analyses of more than 60,000 patients found dabigatran etexilate was linked to fewer major bleeds and strokes than warfarin.
Children exposed to antibiotics during the second or third trimester of pregnancy have an 84% higher risk of being obese at age 7 compared with children who were not exposed to the drugs in utero, according to new research published in the Journal of Obesity.
A long-term study of Celgene Corporation’s apremilast showed that the oral selective inhibitor of phosphodiesterase 4 provides relief to adult patients with active psoriatic arthritis, as well as adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
Latest Issues
$auto_registration$